Results 161 to 170 of about 3,026,820 (400)
Radiative Accelerations in Stellar Evolution [PDF]
arXiv, 2008 A brief review of various methods to calculate radiative accelerations for stellar evolution and an analysis of their limitations are followed by applications to Pop I and Pop II stars. Recent applications to Horizontal Branch (HB) star evolution are also described. It is shown that models including atomic diffusion satisfy Schwarzschild's criterion on
arxiv
Lithium abundance evolution in open clusters: Hyades, NGC752, and M67
, 2013 Mixing mechanisms bring the Li from the base of the convective zone to deeper and warmer layers where it is destroyed. These mechanisms are investigated by comparing observations of Li abundances in stellar atmospheres to models of stellar evolution ...
Castro, Matthieu +2 more
core +1 more source
Molecular Oncology, EarlyView.Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink +6 more
wiley +1 more source
The new Toulouse-Geneva Stellar Evolution Code including radiative accelerations of heavy elements
, 2012 Atomic diffusion has been recognized as an important process that has to be considered in any computations of stellar models. In solar-type and cooler stars, this process is dominated by gravitational settling, which is now included in most stellar ...
Alecian, G. +3 more
core +2 more sources
Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells
Molecular Oncology, EarlyView.In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi +3 more
wiley +1 more source
Modelling Time-dependent Convective Penetration in 1D Stellar Evolution
The Astrophysical JournalOne-dimensional stellar evolution calculations produce uncertain predictions for quantities like the age, core mass, core compactness, and nucleosynthetic yields; a key source of uncertainty is the modeling of interfaces between regions that are ...
Cole Johnston +9 more
doaj +1 more source
Molecular Oncology, EarlyView.Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker +14 more
wiley +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
Correlations between Ca ii H and K Emission and the Gaia M Dwarf Gap
The Astrophysical JournalThe Gaia M dwarf gap, also known as the Jao Gap, is a novel feature discovered in the Gaia Data Release 2 G versus BP-RP color–magnitude diagram. This gap represents a 17% decrease in stellar density in a thin magnitude band around the convective ...
Emily M. Boudreaux +2 more
doaj +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source